CA
ZYME icon

Cliff Asness’s Zymeworks ZYME Stock Holding History

Cliff Asness’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.91M Buy
111,282
+20,613
+23% +$524K ﹤0.01% 2375
2026
Q1 		$2.27M Sell
90,669
-406
-0.4% -$9.61K ﹤0.01% 2262
2025
Q4 		$2.4M Sell
91,075
-61,557
-40% -$1.34M ﹤0.01% 2027
2025
Q3 		$2.61M Sell
152,632
-13,511
-8% -$193K ﹤0.01% 1819
2025
Q2 		$2.09M Buy
166,143
+117,658
+243% +$1.4M ﹤0.01% 1745
2025
Q1 		$577K Buy
48,485
+22,411
+86% +$306K ﹤0.01% 2343
2024
Q4 		$382K Buy
26,074
+1,212
+5% +$16.9K ﹤0.01% 2385
2024
Q3 		$312K Sell
24,862
-69,410
-74% -$756K ﹤0.01% 2377
2024
Q2 		$802K Sell
94,272
-395,230
-81% -$3.52M ﹤0.01% 1853
2024
Q1 		$5.15M Sell
489,502
-196,688
-29% -$2.18M 0.01% 973
2023
Q4 		$7.13M Sell
686,190
-113,489
-14% -$904K 0.01% 820
2023
Q3 		$5.07M Buy
799,679
+330,213
+70% +$2.44M 0.01% 924
2023
Q2 		$4.06M Buy
+469,466
New +$4.2M 0.01% 977
2022
Q2 		– Sell
-12,445
Closed -$82K – 2315
2022
Q1 		$82K Buy
+12,445
New +$111K ﹤0.01% 2151

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Cliff Asness's ZYME Position: Q2 2026 in Review

Cliff Asness increased its Zymeworks (ZYME) stake by 23% in Q2 2026, buying an estimated $524K and bringing the position to 111,282 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

Cliff Asness first reported a position in ZYME in Q1 2022 and has held it in 14 quarters since. The position peaked at $7.13M in Q4 2023. 201 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Cliff Asness held 111,282 shares of Zymeworks worth $2.91M as of Q2 2026.
  • Cliff Asness bought 20,613 Zymeworks shares in Q2 2026, an estimated $524K.
  • Zymeworks made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2375 holding.
  • Cliff Asness first reported a position in Zymeworks in Q1 2022 and has held it in 14 quarters since.
  • Cliff Asness's Zymeworks position peaked at $7.13M in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.